Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 3, 2009, Pages

  Antkowiak, Patrick F ^a   Tersey, Sarah A ^d   Carter, Jeffrey D ^b   Vandsburger, Moriel H ^a   Nadler, Jerry L ^e   Epstein, Frederick H ^a,c   Mirmira, Raghavendra G ^d  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Islet

Indexed keywords

GLUCOSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; STREPTOZOCIN; VOLTAGE GATED CALCIUM CHANNEL; DIAGNOSTIC AGENT; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; INSULIN-SECRETING CELLS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MICE; MICE, INBRED C57BL;

EID: 64749099588     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90336.2008     Document Type: Article

References (21)

1. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 139: 1115-1124, 1998. (Pubitemid 28510130)
2. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414: 788-791, 2001.
3. Evgenov NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 12: 144-148, 2006. (Pubitemid 43050090)
4. Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, Moore A. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 55: 2419-2428, 2006.
5. Fowler M, Virostko J, Chen Z, Poffenberger G, Radhika A, Brissova M, Shiota M, Nicholson WE, Shi Y, Hirshberg B, Harlan DM, Jansen ED, Powers AC. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 79: 768-776, 2005. (Pubitemid 40546195)
6. Gimi B, Leoni L, Oberholzer J, Braun M, Avila J, Wang Y, Desai T, Philipson LH, Magin RL, Roman BB. Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 15: 195-203, 2006. (Pubitemid 43726195)
7. Grimm J, Potthast A, Wunder A, Moore A. Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer. Int J Cancer 106: 806-811, 2003. (Pubitemid 36993405)
8. 2+ and amplification signals in beta-cells. Diabetes 55: 441-451, 2006.
9. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev 15: 111-127, 2001. (Pubitemid 32107658)
10. Koretsky AP, Silva AC. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 17: 527-531, 2004.
11. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55: 1-12, 2006. (Pubitemid 43343293)
12. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 1: 429-435, 2006.
13. Meyer CH, Hu BS, Nishimura DG, Macovski A. Fast spiral coronary artery imaging. Magn Reson Med 28: 202-213, 1992. (Pubitemid 23027662)
14. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812, 2006. (Pubitemid 44033300)
15. Robertson RP. Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes 56: 2420-2424, 2007.
16. Roth DJ, Jansen ED, Powers AC, Wang TG. A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-kappaB transgenic mouse model. Transplantation 81: 1185-1190, 2006.
17. Silva AC, Lee JH, Aoki I, Koretsky AP. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 17: 532-543, 2004. (Pubitemid 40124779)
18. 11C]DTBZ. Nucl Med Biol 33: 855-864, 2006.
19. Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M, Kilbourn M, Goland R, Leibel R, Mann JJ, Van Heertum R, Harris PE. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 116: 1506-1513, 2006. (Pubitemid 43911005)
20. Thorens B. GLUT2 in pancreatic and extra-pancreatic gluco-detection. Mol Membr Biol 18: 265-273, 2001. (Pubitemid 34052686)
21. Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47: 50-56, 1998. (Pubitemid 28030807)